Andre Bosly

Andre Bosly

UNVERIFIED PROFILE

Are you Andre Bosly?   Register this Author

Register author
Andre Bosly

Andre Bosly

Publications by authors named "Andre Bosly"

Are you Andre Bosly?   Register this Author

48Publications

1636Reads

27Profile Views

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

J Clin Oncol 2017 Aug 20;35(22):2473-2481. Epub 2017 Apr 20.

Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis; Diderot University, Sorbonne Paris-Cité; Catherine Thieblemont and Josette Briere, Descartes University; Josette Briere, Hôpital Necker, Paris; Hervé Tilly, University of Rouen, Institut National de la Santé et de la Recherche Médicale U1245, Rouen; Rene-Olivier Casasnovas, Centre Hospitalier Universitaire Dijon; Institut National de la Santé et de la Recherche Médicale UMR1231, Dijon; Christophe Fruchart, Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire, Caen; Franck Morschhauser, Centre Hospitalier Universitaire Régional de Lille, Lille; Corinne Haioun and Philippe Gaulard, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Mondor; Philippe Gaulard, Institut National de la Santé et de la Recherche Médicale U955; Université Paris-Est, Créteil; Julien Lazarovici, Gustave Roussy Cancer Center, Villejuif; Aurore Perrot, University Hospital, Vandoeuvre les Nancy; Catherine Sebban, Centre Leon Berard, University Claude Bernard Lyon 1; Gilles Salles, Hospices Civils de Lyon, Université Claude Bernard U1052, Lyon; Hugo Gonzalez, Centre Hospitalier René Dubos, Pontoise; Reda Bouabdallah, Institut Paoli Calmettes, Marseille; Lucie Oberic, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse; Bernadette Corront, Centre Hospitalier Régional Annecy, Annecy; Bachra Choufi, Centre Hospitalier Dr Duchenne, Boulogne-sur-mer; Gilles Salles and Bertrand Coiffier, Institut National de la Santé et de la Recherche Médicale U1052, Hospices Civils de Lyon, Pierre-Benite, France; Maria Gomes da Silva and Jose Cabeçadas, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal; Anida Grosicka, Medical University of Silesia, Katowice, Poland; Judith Trotman, Concord Repatriation General Hospital, University of Sydney, Concord; John Catalano, Frankston Hospital and Monash University, Frankston, Australia; Dolores Caballero, Hospital Universitario de Salamanca, Salamanca; Armando Lopez-Guillermo, Hospital Clinic Barcelona, Barcelona, Spain; Richard Greil, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute; Arbeitsgemeinschaft Medikamentöse Tumortherapie, Salzburg, Austria; Koen van Eygen, Algemeen Ziekenhuis Groeninge Hospital, President Kennedylaan 4, Kortrijk; Achiel Van Hoof, Algemeen Ziekenhuis Sint Jan AV, Brugge; Andre Bosly, UCL Mont Godinne, Yvoir, Belgium; and Amos M. Cohen, Rabin Medical Center, Beilinson Hospital, Davidoff Cancer Center, Tel-Aviv University, Ramat-Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6984DOI Listing
August 2017

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

J Clin Oncol 2017 Jun 29;35(17):1905-1912. Epub 2017 Mar 29.

Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andrés J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia; Umberto Vitolo, University-Hospital Città della Salute e della Scienza, Turin; Maurizio Martelli, Sapienza University; Stefan Hohaus, Catholic University of the Sacred Heart, Rome; Graziella Pinotti, Fondazione Macchi Hospital, Varese; Caterina Stelitano, Bianchi-Melacrino-Morelli Hospitals, Reggio Calabria; Monica Bellei, University of Modena and Reggio Emilia, Modena, Italy; Reda Bouabdallah, Institut Paoli-Calmettes, Marseille; Gilles Salles, Hospices Civils de Lyon and Université Claude Bernard Lyon-1, Pierre-Benite; Catherine Sebban, Centre Léon Bérard, Lyon; Franck Morschhauser, Claude Huriez Hospital, Lille; Anne Moreau, University Hospital of Nantes, Nantes; Hervé Tilly, Centre Henri Becquerel, Rouen; Corinne Haioun, Henri-Mondor Hospital, Paris Créteil; Corinne Haioun, UPEC, Assistance Publique-Hopitaux de Paris; Catherine Thieblemont, Assistance Publique-Hopitaux de Paris, Hôpital-Saint-Louis, Hematooncology-Université Paris Diderot, Sorbonne Paris-Cité, Paris, France; Ruth Pettengell, St George's University of London, London; Andrew Jack, St James's University Hospital, Leeds; Peter Johnson, Southampton General Hospital, Southampton, United Kingdom; Armando Lopez Guillermo and Elias Campo, Hospital Clinic, Barcelona, Spain; Pierre Zachée, ZNA Stuivenberg, Antwerp; and André Bosly, Mont-Godinne UCL, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.6994DOI Listing
June 2017

BEACOPPescalated versus ABVD in advanced Hodgkin's lymphoma.

Lancet Oncol 2013 Sep 13;14(10):911-2. Epub 2013 Aug 13.

CHU UCL Mont-Godinne-Dinant, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70382-6DOI Listing
September 2013

High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).

Support Care Cancer 2012 Jan 25;20(1):23-8. Epub 2010 Nov 25.

Department of Medical Oncology, University Hospital Ghent, De Pintelaan 185, 9000, Ghent, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-010-1045-0DOI Listing
January 2012

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.

Transfusion 2009 Jul 31;49(7):1412-22. Epub 2009 Mar 31.

The Transfusion Center, Cliniques Universitaires de Mont Godinne, Université Catholique de Louvain, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2009.02151.xDOI Listing
July 2009

A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.

Br J Haematol 2009 Jul 19;146(2):171-9. Epub 2009 May 19.

University of Alabama at Birmingham, Comprehensive Cancer Center, 1824 Sixth Avenue South, Birmingham, AL 35294-3300, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2009.07740.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2009.07740.xDOI Listing
July 2009

Rituximab and chemotherapy in diffuse large B-cell lymphoma.

Expert Rev Anticancer Ther 2009 Jun;9(6):719-26

Mont-Godinne University Hospital, Hematology Department, Avenue Thérasse, 1, 5530 Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.09.30DOI Listing
June 2009

Unsuspected FDG-PET findings in the follow-up of patients with lymphoma.

Ann Hematol 2007 Jan 5;86(1):9-15. Epub 2006 Oct 5.

Department of Hematology, Mont-Godinne Medical Center, Université Catholique de Louvain, 1 Dr. G. Therasse, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-006-0167-4DOI Listing
January 2007

Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment.

Support Care Cancer 2006 Sep 19;14(9):901-9. Epub 2006 Apr 19.

European Center of Pharmaceutical Medicine, University of Basel, University Hospital, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-006-0034-9DOI Listing
September 2006

AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy.

Blood 2006 May 12;107(10):3832-40. Epub 2006 Jan 12.

Institut Universitaire d'Hématologie-GELA, INSERM U728-Hôpital Saint Louis-AP-HP-1, Avenue Claude Vellefaux, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-09-3600DOI Listing
May 2006

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.

N Engl J Med 2005 Mar;352(12):1197-205

Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa042040DOI Listing
March 2005

Treatment of relapses in aggressive non Hodgkin's lymphoma.

Authors:
André Bosly

Bull Cancer 2004 Jul-Aug;91(7-8):E261-73

Université Catholique de Louvain, Department of Hematology, Mont-Godinne University Hospital, 5530 Yvoir, BELGIUM.

View Article

Download full-text PDF

Source
December 2004

FDG PET utility in paraneoplastic sweet syndrome.

Clin Nucl Med 2004 Feb;29(2):91-2

Department of Nuclear Medicine, Mont-Godinne Medical Center, Université Catholique de Louvain, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.rlu.0000109330.67331.86DOI Listing
February 2004

Rituximab in B-cell disorders other than non-Hodgkin's lymphoma.

Anticancer Drugs 2002 Nov;13 Suppl 2:S25-33

Cliniques Universitaires, Mont-Godinne/Yvoir, Belgium.

View Article

Download full-text PDF

Source
November 2002

Prognosis of hematologic malignancies does not predict intensive care unit mortality.

Crit Care Med 2002 Oct;30(10):2260-70

Department of Critial Care Medicine, Cliniques Universitaires de Mont-Godinne, Université Catholique de Louvain, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ccmjournal/2002/10000/Prognosis
Web Search
http://dx.doi.org/10.1097/00003246-200210000-00014DOI Listing
October 2002